The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials

被引：463

作者：

Barker, Timothy Hugh ^{[1
]}

Stone, Jennifer C. ^{[1
]}

Sears, Kim ^{[2
]}

Klugar, Miloslav ^{[3
,4
]}

Tufanaru, Catalin ^{[5
]}

Leonardi-Bee, Jo ^{[6
]}

Aromataris, Edoardo ^{[1
]}

Munn, Zachary ^{[1
]}

机构：

[1] Univ Adelaide, Fac Hlth & Med Sci, JBI, Adelaide, SA, Australia

[2] Queens Univ, Queens Collaborat Hlth Care Qual, Kingston, ON, Canada

[3] Czech Natl Ctr Evidence Based Healthcare & Knowled, Cochrane, Czech Republic

[4] Masaryk Univ, Inst Biostat & Anal, Fac Med, Czech Republ Middle European Ctr Evidence Based He, Brno, Czech Republic

[5] Macquarie Univ, Australian Inst Hlth Innovat, Ctr Hlth Informat, Sydney, NSW, Australia

[6] Univ Nottingham, Nottingham Ctr Evidence Based Healthcare: JBI Ctr, Sch Med, Nottingham, England

来源：

JBI EVIDENCE SYNTHESIS | 2023年 / 21卷 / 03期

基金：

澳大利亚国家健康与医学研究理事会;

关键词：

critical appraisal tool; methodological quality; methodology; randomized controlled trial; risk of bias;

D O I：

10.11124/JBIES-22-00430

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

JBI recently began the process of updating and revising its suite of critical appraisal tools to ensure that these tools remain compatible with recent developments within risk of bias science. Following a rigorous development process led by the JBI Effectiveness Methodology Group, this paper presents the revised critical appraisal tool for the assessment of risk of bias for randomized controlled trials. This paper also presents practical guidance on how the questions of this tool are to be interpreted and applied by systematic reviewers, while providing topical examples. We also discuss the major changes made to this tool compared to the previous version and justification for why these changes facilitate best-practice methodologies in this field.

引用

页码：494 / 506

页数：13

共 16 条

[1]

Aromataris E., 2020, JBI manual for Evidence Synthesis, DOI [DOI 10.46658/JBIMES-20-01, 10.46658/jbimes-20-01]

[2] JBI series paper 2: tailored evidence synthesis approaches are required to answer diverse questions: a pragmatic evidence synthesis toolkit from JBI [J].

Aromataris, Edoardo ;

Stern, Cindy ;

Lockwood, Craig ;

Barker, Timothy H. ;

Klugar, Miloslav ;

Jadotte, Yuri ;

Evans, Catrin ;

Ross-White, Amanda ;

Lizarondo, Lucylynn ;

Stephenson, Matthew ;

McArthur, Alexa ;

Jordan, Zoe ;

Munn, Zachary .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 2022, 150 :196-202

[3]

Atkins D, 2004, Bmj, V328, P1490, DOI DOI 10.1136/BMJ.328.7454.1490

[4]

Barker TH, 2023, JBI Evid Synth, V21

[5]

Greenland S, 2001, Biostatistics, V2, P463, DOI 10.1093/biostatistics/2.4.463

[6]

Jordan Z, 2022, J CLIN EPIDEMIOL

[7]

Khalafallah A, 2010, MEDITERR J HEMATOL I, V2, DOI [10.4084/MJHID.2010.005, 10.1136/bmj.l4898]

[8] Methodological quality of case series studies: an introduction to the JBI critical appraisal tool [J].

Munn, Zachary ;

Barker, Timothy Hugh ;

Moola, Sandeep ;

Tufanaru, Catalin ;

Stern, Cindy ;

McArthur, Alexa ;

Stephenson, Matthew ;

Aromataris, Edoardo .

JBI EVIDENCE SYNTHESIS, 2020, 18 (10) :2127-2133

[9] PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews [J].

Page, Matthew J. ;

Moher, David ;

Bossuyt, Patrick M. ;

Boutron, Isabelle ;

Hoffmann, Tammy C. ;

Mulrow, Cynthia D. ;

Shamseer, Larissa ;

Tetzlaff, Jennifer M. ;

Akl, Elie A. ;

Brennan, Sue E. ;

Chou, Roger ;

Glanville, Julie ;

Grimshaw, Jeremy M. ;

Hrobjartsson, Asbjorn ;

Lalu, Manoj M. ;

Li, Tianjing ;

Loder, Elizabeth W. ;

Mayo-Wilson, Evan ;

McDonald, Steve ;

McGuinness, Luke A. ;

Stewart, Lesley A. ;

Thomas, James ;

Tricco, Andrea C. ;

Welch, Vivian A. ;

Whiting, Penny ;

McKenzie, Joanne E. .

BMJ-BRITISH MEDICAL JOURNAL, 2021, 372

[10] Study Selection and Critical Appraisal [J].

Porritt, Kylie ;

Gomersall, Judith ;

Lockwood, Craig .

AMERICAN JOURNAL OF NURSING, 2014, 114 (06) :47-52

← 1 2 →